23rd September 2021 | Pharma Updates
NPPA revises Price of Cadila’s Vitamin D3 Strips
National Pharmaceutical Pricing Authority has revised the retail price of Vitamin D3.
Biomedica set to advance its manufacturing site
Oxford Biomedica hauled in a 50 mn EUR investment from Serum Life Sciences, to further develop its manufacturing site.
Lincoln Pharma buys plant in Mehsana
The Mehsana plant is expected to contribute sales of around 150 cr in the coming years, Lincoln said.
Food and Drug Control Administration launches Ayudmla portal
Gujarat is the first state of India to launch an online licensing, product approvals and digitisation of records.
Goa accounts for 12% of medication production in India: CM
The pharma industry in Goa accounts for 12% of all drugs manufactured in the country, Chief Minister Pramod Sawant said.
Samhita and Cipla together lead a review among Indian drug specialists
The study showed that pharmacists in India want to improve their skills and knowledge to serve patients, and 76% revealed collaborating with healthcare workers to improve outcomes in their localities.
CuraTeQ Biologics submits biosimilar filing with EMA
Aurobindo Pharma’s CuraTeQ Biologic has submitted a Marketing Authorization Application to the European Medical Agency for BP14.